nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Coronavirus vaccine? Join the queue
|
The Lancet Diabetes & Endocrinology, |
|
|
9 |
1 |
p. 1 |
artikel |
2 |
Correction to Lancet Diabetes Endocrinol 2021; 9: 46–52
|
|
|
|
9 |
1 |
p. e1 |
artikel |
3 |
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial
|
Wheeler, David C |
|
|
9 |
1 |
p. 22-31 |
artikel |
4 |
Global 30-day outcomes after bariatric surgery during the COVID-19 pandemic (GENEVA): an international cohort study
|
Singhal, Rishi |
|
|
9 |
1 |
p. 7-9 |
artikel |
5 |
Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
|
Marx, Nikolaus |
|
|
9 |
1 |
p. 46-52 |
artikel |
6 |
Maternal and fetal outcomes in phaeochromocytoma and pregnancy: a multicentre retrospective cohort study and systematic review of literature
|
Bancos, Irina |
|
|
9 |
1 |
p. 13-21 |
artikel |
7 |
Osteoporosis: overlooked in men for too long
|
The Lancet Diabetes & Endocrinology, |
|
|
9 |
1 |
p. 1 |
artikel |
8 |
Phaeochromocytoma and pregnancy: looking towards better outcomes, less fear, and valuable recommendations
|
Pacak, Karel |
|
|
9 |
1 |
p. 2-3 |
artikel |
9 |
SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond
|
Tuttle, Katherine R |
|
|
9 |
1 |
p. 3-5 |
artikel |
10 |
Skin-whitening creams: worth the risk?
|
Burki, Talha |
|
|
9 |
1 |
p. 10 |
artikel |
11 |
Testosterone replacement to prevent type 2 diabetes? Not just yet
|
Sattar, Naveed |
|
|
9 |
1 |
p. 5-6 |
artikel |
12 |
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial
|
Wittert, Gary |
|
|
9 |
1 |
p. 32-45 |
artikel |
13 |
Thyroid cancer in the USA: current trends and outstanding questions
|
Davies, Louise |
|
|
9 |
1 |
p. 11-12 |
artikel |